Haemonetics (HAE) Tops Q1 EPS by 17c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $74.88 -0.19%
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.59, $0.17 better than the analyst estimate of $0.42. Revenue for the quarter came in at $229.3 million versus the consensus estimate of $219.95 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.17.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- Cosmos Health posts 31% revenue gain in Q2 and H1 2026
- Redwood Trust reports record Aspire quarter, launches AI pricing tools
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
